Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,937 DKK | +0.31% | +0.55% | -10.12% |
May. 21 | Genmab A/S Reaffirms Financial Guidance for 2024 | CI |
May. 21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 18.16B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab : Promising 2022; even the softer 2023 guidance isn’t a worry